The med-tec company PolarCool AB (publ) continues to establish the PolarCap® in ice hockey, by signing a two-year agreement with Norwegian ice hockey giant Vålerenga Ishockey.
PolarCool develops and markets PolarCap®, which alleviates the effects of concussion. The primary users of PolarCap® include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, as well as other sports with an increased risk of concussion.
The company has a strong foothold in Swedish ice hockey, having a league-wide agreement with the SHL, as well as many agreements with 2nd and 3rd tier Swedish teams. In addition, the establishment of PolarCap® has continued in European ice hockey, with PolarCap now being used by ice hockey teams across five countries – Sweden, Finland, Norway, Switzerland, and Germany.
The agreement with Vålerenga has important strategic value as it is the company’s first agreement on the Norwegian market, even if the financial significance of individual agreements is limited. Vålerenga Hockey will use the PolarCap System for the rest of the 2023 season in an initial evaluation period, with the option to continue into a two-year commercial agreement following the season.
Vålerenga Hockey’s Dr. Anine Nordström comments;
-I am happy that we at Vålerenga Hockey will be able to include the PolarCap System in our routines managing concussions and look forward to getting first-hand experiences.
PolarCool CEO Erik Andersson comments;
-I am pleased that we are progressing into new markets. Our first agreement in Norway is very positive and we now look forward to the continued establishment in this market. Our ambition is for more Norwegian teams to follow and we will also start conversations on the league level to work for a league-wide agreement for next season.
The capital club Vålerenga Ishockey plays in the Norwegian top league, the Fjortkraft league, and the club is one of the most successful in Norwegian hockey with 30 league titles and famous players such as Espen ”Shampo” Knutsen.
For more information
Erik Andersson – CEO PolarCool AB (publ)
+46 – 738 60 57 00
E-mail: erik.andersson@polarcool.se
About PolarCool AB (publ)
PolarCool AB (publ) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.